Primary Site >> Liver Cancer

Gene >> SSTR2

Journal: J Pathol. 2000 Oct;192(2):207-15.
Title: Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
Author: Zondervan, P E|Wink, J|Alers, J C|IJzermans, J N|Schalm, S W|de Man, R A|van Dekken, H
PMID: 11004697
Journal: Int J Oncol. 2000 Jun;16(6):1197-201.
Title: Treatment of hepatocellular cancer with the long acting somatostatin analog lanreotide in vitro and in vivo.
Author: Raderer, M|Hejna, M H|Muller, C|Kornek, G V|Kurtaran, A|Virgolini, I|Fiebieger, W|Hamilton, G|Scheithauer, W
PMID: 10811995
Journal: Semin Nucl Med. 2002 Apr;32(2):148-55.
Title: In- and Y-DOTA-lanreotide: results and implications of the MAURITIUS trial.
Author: Virgolini, Irene|Britton, Keith|Buscombe, John|Moncayo, Roy|Paganelli, Giovanni|Riva, Pietro
PMID: 11965610
Journal: J Hepatol. 2004 Jul;41(1):112-8.
Title: Differential expression of somatostatin receptor subtypes in hepatocellular carcinomas.
Author: Blaker, Michael|Schmitz, Michael|Gocht, Andreas|Burghardt, Sylvia|Schulz, Martina|Broring, Dieter C|Pace, Andrea|Greten, Heiner|De Weerth, Andreas
PMID: 15246216
Journal: Acta Pharmacol Sin. 2004 Oct;25(10):1380-6.
Title: Octreotide inhibits proliferation and induces apoptosis of hepatocellular carcinoma cells.
Author: Liu, Hai-lin|Huo, Li|Wang, Lei
PMID: 15456543
Journal: World J Gastroenterol. 2005 Jul 7;11(25):3953-7.
Title: Somatostatin receptor subtype 2-mediated scintigraphy and localization using (99m)Tc-HYNIC-Tyr(3)-octreotide in human hepatocellular carcinoma-bearing nude mice.
Author: Li, Yong|Si, Jian-Ming|Zhang, Jun|Du, Jin|Wang, Fan|Jia, Bing
PMID: 15991301
Journal: Zhonghua Wai Ke Za Zhi. 2005 Jun 1;43(11):721-5.
Title: [The study of inhibition effect of octreotide on the growth of hepatocellular carcinoma xenografts in situ in nude mice].
Author: Hua, Yun-peng|Huang, Jie-fu|Liang, Li-jian|Li, Shao-qiang|Lai, Jia-ming|Liang, Hui-zhen
PMID: 16008961
Journal: Ai Zheng. 2007 Jul;26(7):688-92.
Title: [Correlation of somatostatin receptor expression in human hepatocellular carcinoma tissue to serum alpha-fetoprotein concentration].
Author: Xie, Yong-Mei|Yan, Lu-Nan|Wei, Bing|Guo, Mei-Mei|Tang, Cheng-Wei
PMID: 17626741
Journal: Ai Zheng. 2009 Jul;28(7):673-8.
Title: [Effects of octreotide on necrosis of hepatocellular carcinoma xenografts in nude mice].
Author: Chen, Shuang|Xie, Yan|Wang, Chun-Hui|Tang, Cheng-Wei
PMID: 19624890
Journal: Zhonghua Gan Zang Bing Za Zhi. 2009 Oct;17(10):759-64.
Title: [Induction of necrosis in the hepatocellular carcinoma HepG2 xenografts treated with SOM230].
Author: Xie, Yan|Chen, Shuang|Wang, Chun-Hui|Tang, Cheng-Wei
PMID: 19874692
Journal: Chemotherapy. 2009;55(5):312-20.
Title: Mechanisms and influence of octreotide-induced regulation of somatostatin receptor 2 on hepatocellular carcinoma.
Author: Hua, Yun-Peng|Yin, Xiao-Yu|Peng, Bao-Gang|Li, Shao-Qiang|Lai, Jia-Ming|Liang, Hui-Zhen|Liang, Li-Jian
PMID: 19590186
Journal: Acta Gastroenterol Belg. 2012 Jun;75(2):270-3.
Title: Lanreotide treatment of metastatic hepatocellular carcinoma resulting in partial regression and more than 3 years of progression-free survival.
Author: Borbath, Ivan|Lhommel, Renaud|Guiot, Yves|Coche, Emmanuel|Sempoux, Christine
PMID: 22870795
Journal: Oncol Lett. 2013 Sep;6(3):821-828.
Title: Somatostatin receptor subtypes 2 and 5 are associated with better survival in operable hepatitis B-related hepatocellular carcinoma following octreotide long-acting release treatment.
Author: Liu, Yao|Jiang, Li|Mu, Yi
PMID: 24137418
Journal: Tumour Biol. 2014 Mar;35(3):2497-502.
Title: Hepatic somatostatin receptor 2 expression during premalignant stages of hepatocellular carcinoma.
Author: Abdel-Hamid, N M|Mohafez, O M|Zakaria, S|Thabet, K
PMID: 24163059
Journal: Mol Imaging Biol. 2015 Jun;17(3):313-8.
Title: SUV of [68Ga]DOTATOC-PET/CT Predicts Response Probability of PRRT in Neuroendocrine Tumors.
Author: Kratochwil, C|Stefanova, M|Mavriopoulou, E|Holland-Letz, T|Dimitrakopoulou-Strauss, A|Afshar-Oromieh, A|Mier, W|Haberkorn, U|Giesel, F L
PMID: 25319765
Journal: Histopathology. 2017 Feb;70(3):492-498.
Title: Somatostatin receptors in resected hepatocellular carcinoma: status and correlation with markers of poor prognosis.
Author: Lequoy, Marie|Desbois-Mouthon, Christele|Wendum, Dominique|Gupta, Vandana|Blachon, Jean-Luc|Scatton, Olivier|Dumont, Sylvie|Bonnemaire, Mireille|Schmidlin, Fabien|Rosmorduc, Olivier|Fartoux, Laetitia
PMID: 27391928
Journal: Sichuan Da Xue Xue Bao Yi Xue Ban. 2017 Jul;48(4):549-555.
Title: [Differences of Therapeutic Efficacy Between Different Kinds of Somatostatin Analogue for Primary Hepatocellular Carcinoma].
Author: Lu, Xiu-He|Wang, Chun-Hui|Xie, Yan
PMID: 28752973
Journal: BMC Cancer. 2017 Dec 28;17(1):896.
Title: Somatostatin and CXCR4 chemokine receptor expression in hepatocellular and cholangiocellular carcinomas: tumor capillaries as promising targets.
Author: Kaemmerer, Daniel|Schindler, Robin|Mussbach, Franziska|Dahmen, Uta|Altendorf-Hofmann, Annelore|Dirsch, Olaf|Sanger, Jorg|Schulz, Stefan|Lupp, Amelie
PMID: 29282035